Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.The European Commission (EC) and the UK Government have entered into separate agreements for the supply of potential Covid-19 vaccines.
The EC concluded an agreement with AstraZeneca for up to 400 million doses of the Covid-19 vaccine candidate AZD1222. This marks the first deal signed by the EC for a Covid-19 vaccine.
The deal builds on an existing agreement with Europe’s Inclusive Vaccines Alliance led by Germany, France, Italy and the Netherlands.
The latest agreement will provide European Union (EU) member states the option to access AstraZeneca’s vaccine equally at zero profit during the pandemic.